Eversept Partners »

Anteris Technologies Global shares owned by Eversept Partners

Quarter-by-quarter ownership of Anteris Technologies Global (AVR) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Anteris Technologies Global

Tip: Access up to 7 years of quarterly data

All positions including Anteris Technologies Global held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anteris Technologies Global by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 500k 4.50

More positions owned by Eversept Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Uniqure Nv SHS (QURE)
Hca Holdings (HCA)
Miragen Therapeutics (VRDN)
Zimvie (ZIMV)
Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals (IONS)
PerkinElmer (RVTY)
Travere Therapeutics (TVTX)

View all positions for Eversept Partners

Top funds holding Anteris Technologies Global

L1 Capital Pty
Nantahala Capital Management
BlackRock
Sio Capital Management
Perceptive Advisors
Jpmorgan Chase & Co
Ensign Peak Advisors
Rhenman & Partners Asset Management AB
Geode Capital Management
Vanguard Group
Alyeska Investment Group
Eversept Partners
Affinity Asset Advisors
State Street Corporation
Northern Trust

View all funds holding Anteris Technologies Global